<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 31-year-old man with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> developed erythematous purpuric plaques distributed over the lower chest, abdomen and upper thighs </plain></SENT>
<SENT sid="1" pm="."><plain>Biopsy of lesional skin revealed intravascular proliferation of endothelial cells with associated microthrombi formation </plain></SENT>
<SENT sid="2" pm="."><plain>The histological pattern was consistent with reactive <z:e sem="disease" ids="C0334660" disease_type="Neoplastic Process" abbrv="">angioendotheliomatosis</z:e>, a rare reactive pattern seen associated with disparate medical conditions </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis of the reactive <z:e sem="disease" ids="C0334660" disease_type="Neoplastic Process" abbrv="">angioendotheliomatosis</z:e> in our patient was suspected to be related to his procoagulant state; <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> formed despite a therapeutic international normalized ratio while on <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>His lesions began to resolve with the cessation of <z:chebi fb="8" ids="10033">warfarin</z:chebi> and commencement of subcutaneous enoxaparin, oral <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> and oral aspirin </plain></SENT>
<SENT sid="5" pm="."><plain>The skin biopsy findings were pivotal in influencing the change of therapy in this patient and decreasing his immunosuppression </plain></SENT>
</text></document>